enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hepatitis C - Wikipedia

   en.wikipedia.org/wiki/Hepatitis_C

   Treatment with antiviral medication is recommended for all people with proven chronic hepatitis C who are not at high risk of death from other causes. [87] People with the highest complication risk, which is based on the degree of liver scarring, should be treated first. [ 87 ]

3. List of antiviral drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_antiviral_drugs

   List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year approved Abacavir: HIV: ViiV Healthcare: Nucleoside analogue reverse transcriptase inhibitor (NRTI) 1998 Acyclovir (Aciclovir) Herpes Simplex, chickenpox, [2] varicella zoster virus: GSK: guanosine analogue RTI 1981 Adefovir: Hepatitis B [3] Gilead Sciences RTI 2002 , 2003 ...

4. Antiviral drug - Wikipedia

   en.wikipedia.org/wiki/Antiviral_drug

   The DAA drugs against hepatitis C are taken orally, as tablets, for 8 to 12 weeks. [56] The treatment depends on the type or types of hepatitis C virus that are causing the infection. [57] Both during and at the end of treatment, blood tests are used to monitor the effectiveness of the treatment and subsequent cure. [56]

5. Here's What Hepatitis C Actually Is—and How You Get It - AOL

   www.aol.com/lifestyle/heres-hepatitis-c-actually...

   In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.

6. What People Who Inject Drugs Should Know about Hepatitis C ...

   www.aol.com/lifestyle/people-inject-drugs-know...

   Hepatitis C treatment guidelines also vary based on whether you have cirrhosis (scarring of the liver) and how severe it is. ... Status of Direct-acting Antiviral Therapy for HCV Infection and ...

7. NS5B inhibitor - Wikipedia

   en.wikipedia.org/wiki/NS5B_inhibitor

   The hepatitis C virus non-structural protein 5B has become a target of choice for the development of anti-hepatitis C virus drugs, as it is not expressed in cells that are not infected by hepatitis C virus. [6] The treatment for patients with chronic hepatitis C that was used prior to the development of direct-acting antivirals was ribavirin ...